-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$50.80499.76% Upside
Novavax, Inc. Frequently Asked Questions
-
What analysts cover Novavax, Inc.?
Novavax, Inc. has been rated by research analysts at B.Riley Financial, Jefferies, Bank of America Securities, H.C. Wainwright, Cantor Fitzgerald in the past 90 days.